Navigation Links
FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
Date:11/30/2007

ned to either Cymbalta at the same dose or to a sugar pill for 6 months. Patients on Cymbalta experienced a statistically longer time to relapse of depression than did patients on placebo. Relapse was defined as an increase of two or more points on the Clinical Global Impression - Severity scale (CGI-S) compared with that obtained at week 12, and also meeting the criteria for major depressive disorder for two consecutive visits.

In this study, nausea was the most frequently reported side effect (also referred to as a treatment-emergent adverse event) during the acute phase and was reported as a reason for discontinuation for 2.1 percent of patients. In the continuation phase, there were no significant differences in reported side effects between patients taking Cymbalta compared with those taking sugar pills. Among patients who completed the first 12 weeks of the trial and entered the continuation phase, 3.6 percent reported side effects as reasons for discontinuation over the next 26 weeks (continuation phase) of the study.(2)

Cymbalta, a member of a class of drugs commonly referred to as serotonin and norepinephrine reuptake inhibitors (SNRI), has been studied in more than 27,000 patients worldwide. Cymbalta is already approved for the acute treatment of major depressive disorder, the management of diabetic peripheral neuropathic pain, and for the treatment of generalized anxiety disorder, all in adults. More than 9 million adults in the United States have been prescribed Cymbalta since approval.

About Cymbalta

Serotonin and norepinephrine in the brain and spinal cord are believed to both mediate mood symptoms of depression and help regulate the perception of pain. Based on pre-clinical studies, duloxetine is a balanced and potent reuptake inhibitor of serotonin and norepinephrine that is believed to potentiate the activity of these chemicals in the central nervous system (brain and spinal cord). While the mechanism of action of duloxet
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
4. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
5. SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
6. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
9. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
10. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
11. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 ... and segments the concerned market with analysis and ... $261.8 million in 2014, and is estimated to ... of 19.3% from 2014 to 2019. ... Simulation Market for an analysis of industry trends ...
(Date:6/2/2015)... , June 2, 2015 BioDelivery Sciences International, Inc. ... the presentation by Dr. Mark A. Sirgo , President ... 2:30 PM Eastern time. Jefferies 2015 Global Healthcare ... Hyatt, New York City , NY ... accessed at www.bdsi.com .  For those who are not ...
(Date:6/2/2015)... -- Only a quarter of physicians who prescribe opioids say ... them to, according to new survey results released by ... and myCME , Haymarket Medical Education,s global medical ... director of BUSM,s Safe and Competent Opioid Prescribing ... a critical need for provider education addressing this issue. ...
Breaking Medicine Technology:North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 2North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 3BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 3Survey Results Show Few Doctors Are Very Confident Managing Patients on Opioids 2
... ... Jolla-, ... /PRNewswire-,FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a,biopharmaceutical company ... organization, today announced,that an agreement has been executed licensing classes of ...
... The Quigley,Corporation (Nasdaq: QGLY ) announced positive ... subsidiary, Quigley Pharma Inc., which was,conducted in chickens ... The compound was administered to chicks that had ... from the study indicated,that QR448(a) is efficacious against ...
Cached Medicine Technology:Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 3Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 5
(Date:6/2/2015)... Prussia, PA (PRWEB) June 02, 2015 ... Outsourcing solutions for health plans in the Medicare Advantage, ... participation as a sponsor and exhibitor at AHIP’s Institute ... America’s Health Insurance Plans. The conference will be held ... exhibition booth, #1303, will offer opportunities for attendees to ...
(Date:6/2/2015)... Dallas, TX, USA (PRWEB) June 02, 2015 ... and microsystems, is deploying its growth strategy to benefit ... on BioMEMS: “In Yole Développement’s May 2015 Status of ... market will grow sharply and reach $6.6B in 2020,” ... at Yole Développement . , The analyst adds ...
(Date:6/2/2015)... MedPro Healthcare Staffing, the leading provider of temporary ... the worldwide release of the MedPro Top Jobs app, ... find best jobs that fit their needs. , According ... 10 job seekers report they’re likely to use a ... Top Jobs app gives its users 24/7 mobile access ...
(Date:6/2/2015)... June 02, 2015 Claflin Medical ... has announced the acquisition of RSI Equipment, ... effective May 29th, 2015. , With CME’s recent merger ... latest acquisition joins three premier organizations which specialize in ... and healthcare facilities. By combining forces, they now cover ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 MAP Health ... and revenue cycle management for addiction treatment facilities, announced ... Vice President of Marketing. Mr. Smith will be responsible ... the awareness and visibility of MAP’s core message, products ... was the Marketing Manager at Cottonwood Financial in Irving, ...
Breaking Medicine News(10 mins):Health News:TMG Health to Sponsor and Exhibit at AHIP’s Institute 2015 2Health News:Tronics Aims to Benefit from Major Growth of Sensors and Related Technologies for Healthcare Applications 2Health News:MedPro Healthcare Staffing Launches New MedPro Top Jobs App To Facilitate Job Search For Healthcare Professionals 2Health News:Claflin Medical Equipment (CME) Announces Acquisition of RSI Equipment, Inc. 2Health News:Jared Smith Joins MAP Health Management, LLC, as Vice President of Marketing 2
... understanding of the evolution and spread of viruses like H5N1, ... a consortium, where all// information about the avian influenza will ... on Sharing Avian Influenza Data (GISAID) was announced in ... that was signed by 70 scientists and health officials. Dr. ...
... a vaccine against pneumococcal disease will be introduced for the ... 50 babies and small children a year and prevnt// illness ... national childhood immunisation programme. all babies will be vaccinated against ... months,from Sept.4. Apart from that, in a catch-up programme, infants ...
... analytical capabilities of high-tech laboratory tools, like computers, their ... they have// developed a second generation "lab on a ... first time rapidly and reliably sequences all mitochondrial DNA, ... Diagnostics. Mitochondria which are the energy-producing organelles in cells, ...
... tools such as computers with greater analytical capacities are ... generation "lab on a silicon chip" called the MitoChip ... mitochondrial DNA quickly and reliably. Their report will be ... Molecular Diagnostics. ,The mitochondria have their own ...
... a coordinated global plan, especially in developing countries to ... HIV/AIDS-related cases. ,57 countries, mostly in sub-Saharan ... facing acute shortage. Over 4 million workers are needed ... Train, Retain’ is an essential part of its effort ...
... latest example of growing online interaction between Britain and ... hour for online tuition on various subjects from teachers ... have been receiving such one-to-one tuition using Internet telephony ... employs teachers who work in shifts. ,While ...
Cached Medicine News:Health News:Global avian flu database 2Health News:Global avian flu database 3Health News:Global avian flu database 4Health News:Immunisation programme to include vaccine against Pneumococcal disease 2Health News:High -tech Mitochondrial DNA Sequencing Tool Updated 2Health News:High -tech Mitochondrial DNA Sequencing Tool Updated 3Health News:High -tech Mitochondrial DNA Sequencing Tool Updated 4Health News:MitoChip v2.0 – the new Mitochondrial DNA sequencing too 2Health News:MitoChip v2.0 – the new Mitochondrial DNA sequencing too 3Health News:MitoChip v2.0 – the new Mitochondrial DNA sequencing too 4Health News:British Pupils Opt for Online Tuition from India 2
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (Z37,160-2) ... assistance. Color: colour-coded ...
... These 3mL PYREX volumetric pipets ... tolerances in accordance with ASTM ... pipet is individually serialized and ... Identification and Capacity, traceable to ...
... disposable lever action skin stapler ... that is designed to provide ... work from your normal vantage ... available in four configurations: 35 ...
... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... features:Eppendorf "pipette/tip" system ensures utmost accuracy and ...
Medicine Products: